CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-6.97%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$718M
AUM Growth
+$718M
(-55%)
Cap. Flow
-$782M
Cap. Flow
% of AUM
-108.88%
Top 10 Holdings %
Top 10 Hldgs %
78.87%
Holding
35
New
4
Increased
1
Reduced
16
Closed
9
Top Buys
| 1 |
Icon
ICLR
|
$43.6M |
| 2 |
Merck
MRK
|
$39.6M |
| 3 |
UnitedHealth
UNH
|
$31.2M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$14.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$5.5M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$114M |
| 2 |
Humana
HUM
|
$104M |
| 3 |
Baxter International
BAX
|
$87.8M |
| 4 |
CVS Health
CVS
|
$82.8M |
| 5 |
PTC Therapeutics
PTCT
|
$76.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Structure Therapeutics
GPCR
$1.2B
| – | – |
-300,000
| Closed | -$5.19M |
|
27
GSK
GSK
$79B
| – | – |
0
| – | – |
|
28
Ionis Pharmaceuticals
IONS
$9.58B
| – | – |
-725,000
| Closed | -$21.9M |
|
29
MoonLake Immunotherapeutics
MLTX
$3.89B
| – | – |
-441,000
| Closed | -$17.2M |
|
|
30
PTC Therapeutics
PTCT
$4.36B
| – | – |
-1,500,000
| Closed | -$76.4M |
|
31
Qiagen
QGEN
$10.1B
| – | – |
-1,400,000
| Closed | -$56.2M |
|
32
SPDR S&P 500 ETF Trust
SPY
$655B
| – | – |
0
| – | – |
|
33
Sarepta Therapeutics
SRPT
$1.96B
| – | – |
-800,000
| Closed | -$51.1M |
|
34
10x Genomics
TXG
$1.67B
| – | – |
-1,000,000
| Closed | -$8.73M |
|
35
SPDR S&P Biotech ETF
XBI
$5.32B
| – | – |
0
| – | – |
|